Ronald Buggage, MD, Chief Medical Officer

Ronald brings more than 14 years of experience at large pharma and biotech companies, where he held senior development positions in the United States and Europe. Most recently, Ronald served as a division medical officer in Sanofi’s ophthalmology unit, where he led and coordinated the medical and scientific activities for its ophthalmology portfolio, including development programs for ocular gene therapy. As chief scientific officer of Novagali Pharma, Ronald was responsible for global clinical and regulatory strategy, culminating in its successful acquisition by Santen. Prior to moving to France, Ronald held various positions of increasing clinical development responsibility at Novartis and Pfizer. A graduate of the UCLA School of Medicine, Ronald completed his ophthalmology residency and fellowship at Emory University and completed his training in ocular immunology and uveitis at the National Eye Institute of the National Institutes of Health.